By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AcelRx Pharmaceuticals 

575 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-216-3500 Fax: 650-216-6500




Company News
AcelRx (ACRX) To Hold Third Quarter Financial Results Conference Call And Webcast On Tuesday, November 1st, 2016 10/25/2016 9:30:59 AM
AcelRx (ACRX) Presenting ARX-04 Clinical Trial Findings And Cost Analysis At European Congress On Emergency Medicine 9/28/2016 10:21:52 AM
AcelRx (ACRX) Initiates Phase 3 Study Of Zalviso In Patients With Moderate-To-Severe Acute Post-Operative Pain 9/27/2016 7:19:38 AM
Findings From AcelRx (ACRX)' Phase 3 SAP301 Study Of ARX-04 In Abdominoplasty Patients To Be Presented At Plastic Surgery Meeting 9/23/2016 6:50:37 AM
AcelRx (ACRX) To Present At The Ladenburg Thalmann 2016 Healthcare Conference 9/22/2016 10:31:58 AM
AcelRx (ACRX) Surges as Pain Drug is Found Safe in Final Late-Stage Study 9/15/2016 5:55:02 AM
AcelRx (ACRX) To Participate At Two Upcoming Investor Events In September 8/31/2016 10:57:29 AM
AcelRx (ACRX) Presents Results From Phase 3 Study Of ARX-04 In The Emergency Department At The International Society For Burn Injuries 8/29/2016 8:25:29 AM
AcelRx (ACRX)' ARX-04 Phase 3 Trial Met its Primary Endpoint 8/15/2016 6:31:50 AM
AcelRx (ACRX) To Present Initial Results Of Phase 3 Study Of ARX-04 At World Congress Of Mountain & Wilderness Medicine 8/1/2016 10:12:39 AM